Pegasus Partners Ltd. Gsk PLC Transaction History

Pegasus Partners Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 27, 2018	SELL	$39.61 - $42.76 $222,132 - $239,798	-5,608 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$36.18 - $40.15 $550,876 - $611,323	-15,226 Reduced 73.08%	5,608 $219,000
Q4 2017 Feb 08, 2018	SELL	$35.34 - $41.9 $962,343 - $1.14 Million	-27,231 Reduced 56.65%	20,834 $739,000
Q3 2017 Nov 09, 2017	BUY	$39.44 - $41.55 $1.9 Million - $2 Million	48,065	48,065 $1.95 Million

167K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $82B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Pegasus Partners Ltd. with notifications on news.